Plasma leptin and prognosis in patients with established coronary atherosclerosis.
about
Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosisLean heart: Role of leptin in cardiac hypertrophy and metabolismInflammation and metabolic dysfunction: links to cardiovascular diseasesLeptin, a mediator of cardiac damage associated with obesityRole of C reactive protein (CRP) in leptin resistanceAlterations in mouse hypothalamic adipokine gene expression and leptin signaling following chronic spinal cord injury and with advanced ageAdipokines, linking adipocytes and vascular function in hemodialyzed patients, may also be possibly related to CD146, a novel adhesion moleculeAdiponectin and cardiovascular disease: state of the art?Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis.Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosisRelationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk preventionLeptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells.Adipokines, insulin resistance, and coronary artery calcification.Leptin deficiency recapitulates the histological features of pulmonary arterial hypertension in mice.Anti-obesity effect of an isoflavone fatty acid ester on obese mice induced by high fat diet and its potential mechanismAdipose tissue and vascular inflammation in coronary artery disease.Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study.The Associations of Novel Vitamin D3 Metabolic Gene CYP27A1 Polymorphism, Adiponectin/Leptin Ratio, and Metabolic Syndrome in Middle-Aged Taiwanese Males.Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3.Gender differences in cardiovascular disease: hormonal and biochemical influences.Differential effects of leptin and adiponectin in endothelial angiogenesis.Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial.Effect of increased leptin and C-reactive protein levels on mortality: results from the National Health and Nutrition Examination SurveyMechanisms of thrombosis in obesity.Clinical profiles and risk factors for outcomes in older patients with cervical and trochanteric hip fracture: similarities and differences.Evaluation of leptin and adiponectin levels in patients with stable angina pectoris.Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.The effect of ferulic acid ethyl ester on leptin-induced proliferation and migration of aortic smooth muscle cells.Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population.Serum Leptin Levels and the Risk of Stroke: The Framingham Study.Race-ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN).Leptin, abdominal obesity, and onset of depression in older men and women.Biomarkers of obesity and subsequent cardiovascular eventsMultifaceted leptin network: the molecular connection between obesity and breast cancer.Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.Leptin: the missing link between obesity and heart disease?Sulforaphane improves dysregulated metabolic profile and inhibits leptin-induced VSMC proliferation: Implications toward suppression of neointima formation after arterial injury in western diet-fed obese miceObesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors.
P2860
Q26775340-67260D36-C6CE-436A-B826-D42BC47F4DB7Q26785951-5957FDCC-EDAF-445A-84A5-D289BBB21787Q26851186-30D8F930-FB97-470A-9F39-CA45ABBA1FAFQ26861460-C5F522EA-87A4-4C2C-89D9-7886A0B091DBQ26865632-A70FD3F8-E2DD-4E4A-A13C-885497D4DE51Q27333098-4488A5D8-05F4-485A-8EDD-AB635AD56DD8Q28262860-58D49DCF-8F1E-4FD6-9F8A-0D1344BB395DQ30358456-F1491FE2-7ED9-4032-8D68-F02BD126B677Q30394806-452D6A93-8E44-4557-869B-12E39ECD92CBQ33572695-57B03E22-BB6F-43A3-ABE7-752B2CC7710CQ33627732-9A344819-0915-4E65-B02F-FEEA6EF319A5Q33700633-7A6727D0-5074-4B65-B9C5-C3922062D0D5Q33785169-162F2B0D-6399-487D-9AE2-06F13BE3FC19Q33803046-4D87AE4A-615D-406B-9783-6C7EFFD572B1Q33931073-28F6B741-1688-4F02-B8CF-DB8147F65E29Q33948483-4455C118-3D31-44DF-95C6-57F956F42EAEQ34002877-A70E8138-1196-4FC1-A2F4-9BFA28E92F1FQ34892929-7BF67EC3-39C4-4537-AFF4-10C7716A1EECQ34987757-318B077E-69B7-4EEE-AD95-073F59B3C9F2Q35018331-5D318DBF-A62B-4D03-A06C-B80599E34327Q35023822-37A3BC32-DA19-4AFC-AAE6-3E25F1C2EAE5Q35026566-81FB20A6-82A3-437F-B408-509ED860B91DQ35264479-E3743C7E-5A6E-41FD-B39F-6CBF60FF81E8Q35441429-0CBB6771-C084-4FA1-AD1B-D0E3DA5FAAA1Q35653311-24636B49-E724-4435-AFEE-073F71076A4DQ35809047-8D6AF6EE-5B9E-44C4-9106-05DC31E72DA3Q35945159-A9809867-D2FE-4E88-85E7-F9A2819CAFBBQ36015883-E8395EA3-7640-44BC-90C5-4A080F36B2ABQ36022213-D4B5E7A4-A8F7-496B-BE3F-0FDA6FD2958AQ36025406-0FDC9368-DDD6-4739-826D-4F145E812A8AQ36109091-6066025B-0D3A-4530-B202-E8F74AB65B39Q36113642-DB6958DC-498A-4E31-A9D3-E72F88E7030BQ36364473-A2CDCCB0-713D-4313-8F06-F33283685C94Q36381096-88A21A8F-0DDD-48DE-B33D-31E9B9E4169AQ36561207-F261F256-7883-4342-94CA-EB812A72D50BQ36616558-B8EF9162-3D71-4C7E-8EA2-DA9D668E2684Q36772245-9970229C-4376-4A8B-83B7-CC70848F19C5Q36923666-2BBB8DDF-C89B-4572-AE45-BA236D0705D6Q36951691-ED9FB519-35C3-490B-93A1-2E50BA94672DQ36977876-BEEBEF18-5F2F-4CE0-ABCB-5EA177D45F9F
P2860
Plasma leptin and prognosis in patients with established coronary atherosclerosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Plasma leptin and prognosis in patients with established coronary atherosclerosis.
@en
type
label
Plasma leptin and prognosis in patients with established coronary atherosclerosis.
@en
prefLabel
Plasma leptin and prognosis in patients with established coronary atherosclerosis.
@en
P2093
P1476
Plasma leptin and prognosis in patients with established coronary atherosclerosis
@en
P2093
Bruce D Johnson
Peter Berger
Robert Wolk
Ryan J Lennon
Virend K Somers
P304
P356
10.1016/J.JACC.2004.07.050
P407
P577
2004-11-01T00:00:00Z